Yongfeng Ding

1.6k total citations · 1 hit paper
51 papers, 944 citations indexed

About

Yongfeng Ding is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Yongfeng Ding has authored 51 papers receiving a total of 944 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 14 papers in Molecular Biology. Recurrent topics in Yongfeng Ding's work include Cancer Immunotherapy and Biomarkers (10 papers), Gastric Cancer Management and Outcomes (7 papers) and Ferroptosis and cancer prognosis (6 papers). Yongfeng Ding is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Gastric Cancer Management and Outcomes (7 papers) and Ferroptosis and cancer prognosis (6 papers). Yongfeng Ding collaborates with scholars based in China, United States and Sweden. Yongfeng Ding's co-authors include Haiyong Wang, Lisong Teng, Yimin Lu, Weiqin Jiang, Weixiang Zhong, Yinjun He, Wenguang He, Lu Qi, Guosheng Wu and Xile Zhou and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Scientific Reports.

In The Last Decade

Yongfeng Ding

48 papers receiving 933 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy

2021 225 citations Weiqin Jiang, Yinjun He et al. Frontiers in Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yongfeng Ding China	18	409	305	231	213	150	51	944
Ernesta Cavalcanti Italy	17	580 1.4×	288 0.9×	246 1.1×	126 0.6×	137 0.9×	52	994
Mercedes Gómez‐Morales Spain	17	306 0.7×	382 1.3×	224 1.0×	154 0.7×	92 0.6×	46	1.0k
Eijiro Nakamura Japan	19	574 1.4×	512 1.7×	229 1.0×	472 2.2×	241 1.6×	59	1.4k
Muh‐Hwa Yang Taiwan	16	456 1.1×	465 1.5×	186 0.8×	161 0.8×	245 1.6×	56	1.3k
Daniel A. Zlotoff United States	19	604 1.5×	267 0.9×	608 2.6×	170 0.8×	58 0.4×	48	1.5k
Hironori Hayashi Japan	22	442 1.1×	305 1.0×	131 0.6×	235 1.1×	136 0.9×	97	1.2k
Beth A. Bouchard United States	17	183 0.4×	229 0.8×	152 0.7×	176 0.8×	102 0.7×	36	1.4k
Cristina Pérez-Ramírez Spain	14	211 0.5×	309 1.0×	108 0.5×	161 0.8×	177 1.2×	50	762
Liyi Xie China	16	239 0.6×	345 1.1×	207 0.9×	222 1.0×	276 1.8×	54	1.1k

Countries citing papers authored by Yongfeng Ding

Since Specialization

Citations

This map shows the geographic impact of Yongfeng Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongfeng Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongfeng Ding more than expected).

Fields of papers citing papers by Yongfeng Ding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongfeng Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongfeng Ding. The network helps show where Yongfeng Ding may publish in the future.

Co-authorship network of co-authors of Yongfeng Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Yongfeng Ding. A scholar is included among the top collaborators of Yongfeng Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongfeng Ding. Yongfeng Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Yiran, Yangyang Zheng, Yongfeng Ding, et al.. (2025). Sialic acid metabolism-based classification reveals novel metabolic subtypes with distinct characteristics of tumor microenvironment and clinical outcomes in gastric cancer. Cancer Cell International. 25(1). 61–61. 1 indexed citations

Li, Ning, et al.. (2024). A retrospective study of adjuvant albumin-bound paclitaxel plus S-1 after D2 gastrectomy versus oxaliplatin plus S-1 in gastric cancer. Scientific Reports. 14(1). 15150–15150. 1 indexed citations

Chen, Yiran, Junjie Jiang, Xiaolu Ma, et al.. (2024). New techniques to identify the tissue of origin for cancer of unknown primary in the era of precision medicine: progress and challenges. Briefings in Bioinformatics. 25(2). 10 indexed citations

Yu, Shanshan, Ming Chen, Xiaohua Zhu, et al.. (2024). The combination of exon sequencing and metabolomics to establish a molecular typing system for gastric cancer. Heliyon. 10(15). e34317–e34317. 2 indexed citations

Lian, Jiapan, Yongfeng Ding, Xin Wang, et al.. (2024). Calcium deficiency and its implications for cardiovascular disease and cancer: Strategies for resolution via agronomic fortification. Food Science & Nutrition. 12(11). 8594–8607.

He, Chao, Yongfeng Ding, Yan Yang, et al.. (2023). Stem cell landscape aids in tumor microenvironment identification and selection of therapeutic agents in gastric cancer. Cellular Signalling. 113. 110965–110965. 3 indexed citations

Ding, Yongfeng, Xiaolu Ma, Xiaoyu Chen, et al.. (2023). The Memorial Sloan Kettering Prognostic Score: Correlation with survival in patients with advanced gastric cancer. Cancer Medicine. 12(19). 19656–19666. 2 indexed citations

Ding, Yongfeng, Yu Zhang, Qihan You, et al.. (2023). Combined fine-needle aspiration and selective intraoperative frozen section to optimize prediction of malignant thyroid nodules: A retrospective cohort study of more than 3000 patients. Frontiers in Endocrinology. 14. 1091200–1091200. 5 indexed citations

Wu, Hui, et al.. (2023). Heterogeneity and Adjuvant Therapeutic Approaches in MSI-H/dMMR Resectable Gastric Cancer: Emerging Trends in Immunotherapy. Annals of Surgical Oncology. 30(13). 8572–8587. 13 indexed citations

10.

Yu, Xiongfei, Yiran Chen, Jun Lü, et al.. (2022). Patient-derived xenograft models for gastrointestinal tumors: A single-center retrospective study. Frontiers in Oncology. 12. 985154–985154. 6 indexed citations

11.

Chen, Chuanzhi, Yi Chen, Xin Jin, et al.. (2022). Identification of Tumor Mutation Burden, Microsatellite Instability, and Somatic Copy Number Alteration Derived Nine Gene Signatures to Predict Clinical Outcomes in STAD. Frontiers in Molecular Biosciences. 9. 793403–793403. 4 indexed citations

12.

Chen, Xiangliu, Yingying Huang, Jin Liu, et al.. (2022). EXOSC5 promotes proliferation of gastric cancer through regulating AKT/STAT3 signaling pathways. Journal of Cancer. 13(5). 1456–1467. 6 indexed citations

13.

Ding, Yongfeng, Chenyu Mao, Xiaolu Ma, et al.. (2022). Association of inflammatory markers with survival in patients with advanced gastric cancer treated with immune checkpoint inhibitors combined with chemotherapy as first line treatment. Frontiers in Oncology. 12. 1029960–1029960. 16 indexed citations

14.

Chen, Dong, Xuanwen Bao, Ruyi Zhang, et al.. (2021). Depiction of the genomic and genetic landscape identifies CCL5 as a protective factor in colorectal neuroendocrine carcinoma. British Journal of Cancer. 125(7). 994–1002. 21 indexed citations

15.

Jiang, Haiping, Yuan Gao, Yongfeng Ding, et al.. (2021). Disease progression and pseudoprogression following partial response with rare gingiva metastasis upon IBI308 (sintilimab) immunotherapy reflects the complexity of metastatic lung cancer: a case report. Translational Cancer Research. 10(1). 546–552. 1 indexed citations

16.

Jiang, Weiqin, Yinjun He, Wenguang He, et al.. (2021). Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy. Frontiers in Immunology. 11. 622509–622509. 225 indexed citations breakdown →

17.

Wu, Mengjie, Yongfeng Ding, Xiaoxia Jiang, et al.. (2020). Overexpressed MAGP1 Is Associated With a Poor Prognosis and Promotes Cell Migration and Invasion in Gastric Cancer. Frontiers in Oncology. 9. 1544–1544. 5 indexed citations

18.

Zhou, Jie, Wenyi Zhao, Jingcheng Wu, et al.. (2019). Neoantigens Derived from Recurrently Mutated Genes as Potential Immunotherapy Targets for Gastric Cancer. BioMed Research International. 2019. 1–11. 24 indexed citations

19.

Jiang, Weiqin, Yifei Shen, Yongfeng Ding, et al.. (2017). A naive Bayes algorithm for tissue origin diagnosis (TOD‐Bayes) of synchronous multifocal tumors in the hepatobiliary and pancreatic system. International Journal of Cancer. 142(2). 357–368. 21 indexed citations

20.

Lou, Meng, Qian Liu, Guoping Ren, et al.. (2017). Physical interaction between human ribonucleotide reductase large subunit and thioredoxin increases colorectal cancer malignancy. Journal of Biological Chemistry. 292(22). 9136–9149. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact